[{"Assets_0_Q2_USD":300488000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-61441000.0,"NetIncomeLoss_1_Q2_USD":-34380000.0,"NetIncomeLoss_2_Q2_USD":-63534000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":30069048.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":29950241.0,"StockholdersEquity_0_Q2_USD":-33473000.0,"EarningsPerShareBasic_1_Q2_USD":-1.14,"EarningsPerShareBasic_2_Q2_USD":-2.12,"Ticker":"RETA","CIK":"1358762","name":"REATA PHARMACEUTICALS INC","OfficialName":"Reata Pharmaceuticals Inc. Class A Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1148907684.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190808"}]